Niva Bupa Health Insurance Company Limited has announced an earnings conference call scheduled for May 8, 2026, at 6:30 PM IST to discuss its performance for the quarter and financial year ended March 31, 2026. The company filed this intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conference Call Details

The earnings conference call will be coordinated by ICICI Securities and will feature discussions on Q4FY26 and full-year performance with analysts and investors.

Management Representation

The earnings call will be represented by senior management team including key leadership positions across various business functions.

International Access and Coordination

ICICI Securities has arranged comprehensive access options for international participants with toll-free numbers for multiple regions.

Contact Information

For clarifications and coordination, ICICI Securities has designated multiple contact persons including Mr. Jaideep Goswami (Head of Equities), Mr. Ansuman Deb, and Mr. Shubham Prajapati. Additional support contacts include Mr. Rushad Kapadia, Ms. Seema Sehgal, and Ms. Minali Ginwala.

Regulatory Compliance

The announcement was communicated to both NSE and BSE where the company's shares are listed under symbol NIVABUPA and scrip code 544286 respectively. The intimation was signed by Aparna Sharma, Company Secretary and Compliance Officer, ensuring adherence to corporate governance requirements.

Niva bupa health insurance company Limited has received regulatory clearance from the Insurance Regulatory and Development Authority of India (IRDAI) for a significant equity share transfer by one of its existing investors. The approval covers the proposed transfer of up to 14,62,02,091 equity shares by Fettle Tone LLP.

Regulatory Approval Details

The IRDAI granted its approval through a letter dated April 10, 2026, enabling Fettle Tone LLP to proceed with the equity share transfer. This approval was issued in accordance with established regulatory frameworks governing insurance sector investments and shareholding changes.

Legal Framework

The regulatory approval was granted under specific provisions of insurance sector regulations. The transfer falls under the purview of Section 6A of the Insurance Act, 1938, as amended, read with the IRDAI (Registration, Capital Structure, Transfer of Shares and Amalgamation of Insurers) Regulations, 2024.

These regulations govern various aspects of insurance companies' operations, including:

• Capital structure modifications
• Share transfer approvals
• Registration requirements
• Amalgamation procedures

Compliance Disclosure

The company has fulfilled its disclosure obligations by informing both the National Stock Exchange of India Limited and BSE Limited about this development. This notification was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates timely disclosure of material events and corporate developments.

The disclosure was signed by Aparna Sharma, Company Secretary & Compliance Officer, ensuring proper authorization and compliance with regulatory requirements. The formal communication to stock exchanges maintains transparency with stakeholders regarding significant corporate developments affecting the company's shareholding structure.